All Updates

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

In proposing to increase Maine’s tax on cigarettes $1 per pack, Governor Mills’ has taken a historic step in the fight to curb tobacco product use among Mainers.

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

BISMARCK, N.D. -- As North Dakota legislators close their first week of business for the new year, American Cancer Society Cancer Action Network advocates on Monday will ask them to take strong action to reduce the cost of fighting cancer. ACS CAN volunteers look forward to meeting with lawmakers and

As the 2025 legislative session gets underway, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize improving access to cancer care and increasing funding for tobacco control programs to ease the burden of cancer in Michigan.

Mientras los legisladores inician la sesión legislativa de 2025, ACS CAN los insta a que den prioridad a la aprobación de leyes que alivien el sufrimiento causado por el cáncer entre los habitantes de Illinois.

The following is a statement from American Cancer Society Cancer Action Network (ACS CAN) Maryland Government Relations Director Lance Kilpatrick: “In 2024, Maryland state lawmakers heard from advocates across the disease spectrum and from every corner of the state, who united together to send a resounding message: improve access to lifesaving medication. Though the legislature did not advance the proposal to prohibit the use of copay accumulator adjustment programs, advocates are hopeful that lawmakers won’t miss the same opportunity in 2025.

Mientras los legisladores inician la sesión legislativa de 2025, ACS CAN los insta a que den prioridad a la aprobación de leyes que alivien el sufrimiento causado por el cáncer entre los habitantes de Illinois.